血浆蛋白质组动态变化揭示青光眼诊断前15年窗口:因果洞察与预测效用
该前瞻性队列研究纳入45,850名无基线青光眼的英国生物银行参与者,中位随访16.26年,发现136种血浆蛋白与青光眼风险显著相关,其中4种为因果蛋白;蛋白质组紊乱在临床诊断前12至15年开始,时间分层预测模型对两年内发病的AUC达0.803。
要点
- 血浆蛋白质组紊乱在青光眼临床诊断前12至15年即可检测到。
- LTBP2为因果蛋白,提示细胞外基质重塑和免疫失调参与发病。
- 基于蛋白质组特征的预测模型对两年内发病的AUC为0.803。
核心结论
- 青光眼诊断前存在长达15年的血浆蛋白质组可检测紊乱窗口,因果蛋白LTBP2等提供机制见解和潜在治疗靶点。
- 时间分层预测模型显示出用于风险分层筛查的转化潜力。
研究设计与样本
- 前瞻性队列研究,纳入45,850名无基线青光眼的英国生物银行参与者,中位随访16.26年。
- 使用Olink Explore 3072平台测量2920种血浆蛋白,采用Cox比例风险模型、孟德尔随机化、LOESS回归和时间分层机器学习模型分析。
主要发现
- 随访期间发现977例新发青光眼病例。
- 全面调整后,136种蛋白与青光眼风险显著相关(FDR<0.05),EDA2R关联最强(HR=1.21,95%CI=1.16-1.25,P=2.99×10^-17)。
- 孟德尔随机化识别出四种因果蛋白:LTBP2(OR=1.52,95%CI=1.36-1.71,P=1.07×10^-12)、NRP2(OR=0.85,95%CI=0.78-0.92,P=4.73×10^-5)、TNFSF13和HAVCR1。
- 蛋白质组紊乱在临床诊断前12至15年开始,识别出三种 distinct 时间模式。
- 时间分层预测模型对两年内预测的AUC为0.803(95%CI=0.772-0.837),比人口学模型提高14.65%。
关键数值与推荐
- 136种蛋白与青光眼风险显著相关(FDR<0.05)。
- LTBP2的OR=1.52(95%CI=1.36-1.71,P=1.07×10^-12);NRP2的OR=0.85(95%CI=0.78-0.92,P=4.73×10^-5)。
- 预测模型对两年内发病的AUC=0.803(95%CI=0.772-0.837),比人口学模型提高14.65%。
临床怎么用
- 这些蛋白质组特征可能有助于风险分层筛查,在临床诊断前12至15年识别高风险个体。
- LTBP2等因果蛋白可作为潜在治疗靶点,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize the temporal dynamics of plasma proteomic changes preceding glaucoma diagnosis, identify causal proteins, and evaluate their predictive utility for early detection. METHODS: We conducted a prospective cohort study of 45,850 UK Biobank participants without baseline glaucoma, followed for a median of 16.26 years. Plasma levels of 2920 proteins were measured using the Olink Explore 3072 platform. Cox proportional hazards models identified proteins associated with incident glaucoma. Mendelian randomization (MR) using cis- protein quantitative trait loci established causal relationships. Temporal trajectories were modeled using LOESS regression, and time-stratified machine learning models were developed to assess predictive performance. RESULTS: During follow-up, 977 incident glaucoma cases were identified. After comprehensive adjustment, 136 proteins were significantly associated with glaucoma risk (false discovery rate < 0.05), with EDA2R showing the strongest association (hazard ratio [HR] = 1.21, 95% confidence interval [CI] = 1.16-1.25, P = 2.99 × 10-17). MR analysis identified four causal proteins: LTBP2 (odds ratio [OR] = 1.52, 95% CI = 1.36-1.71, P = 1.07 × 10-12), NRP2 (OR = 0.85, 95% CI = 0.78-0.92, P = 4.73 × 10-5), TNFSF13, and HAVCR1-implicating extracellular matrix remodeling and immune dysregulation in disease pathogenesis. Proteomic dysregulation commenced 12 to 15 years before clinical diagnosis, with three distinct temporal patterns identified. Time-stratified predictive models incorporating these signatures achieved an area under the curve of 0.803 (95% CI = 0.772-0.837) for up to two-year prediction, a 14.65% improvement over demographic models. CONCLUSIONS: This study reveals a 15-year window of detectable plasma proteomic dysregulation preceding glaucoma diagnosis. The identified causal proteins, particularly LTBP2, provide mechanistic insights and represent potential therapeutic targets. The strong predictive performance demonstrates the translational potential of these findings for risk-stratified screening.
引用
- Zhao Y, Wu J, Li C, et al. Plasma Proteomic Dynamics Preceding Glaucoma Reveal a 15-Year Pre-Diagnostic Window: Causal Insights and Predictive Utility in 45,850 Participants. Invest Ophthalmol Vis Sci. 2026. PMID: 41789843. doi:10.1167/iovs.67.3.14
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。